Program

Here you can download the program as PDF.

WEDNESDAY, DECEMBER 10, 2025

7:30 - 10:00 PM | Social event + Dinner

THURSDAY, DECEMBER 11, 2025

8:30 - 10:00 AM | Plenary Session 1: New insights into vacular biology
Chairs: Jes-Niels Böckel / Ulrike Schatz

• Mediators and modulators of atherogensis
  Christoph Binder 
• Novel regulators of endothelial function
  Hellmut Augustin
  
• The function of non-coding RNAs in endothelial lipid signalling
  Ralph Brandes

Scientific Session 1: New insights into lipoprotein function and lipid signalling
Chairs: Heribert Schunkert / Ingo Hilgendorf

• Effects of physical exercise on RNAs in cardiovascular diseases
  Xiao Junjie
• Empedoic acid versus Statins: unique mechanisms of action?
  Bilal Sheikh
• Atherogenicity of apoB-containing lipoproteins
  Jan Boren

Scientific Session 2: Oxlipins - facts and myths
Chairs: Daniel Huster / Trian Chavakis

• Oxylipins in neuroinflammation
  Uta Ceglarek
• LC-MS analysis of oxylipins in biological samples: Good practice and bad examples
  Nils Helge Schebb
• The Modulatory Role of Brown Adipose Tissue on Systemic Lipid Metabolism in Lean and Obese Adults
  Jörg Heeren

Scientific Session 3: Mechanisms of atherogenesis
Chairs: Daniel Sedding / Christoph Binder

• Presentation from selected abstracts
• How Mitochondria Control Cytokines
  Luke O’Neill
• Metabolic reprogramming of immune cells and impact on atherosclerosis
  Hafid Ait-Oufella
• Genetic alterations in the matrisome and atherosclerosis
  Thorsten Kessler
  

Scientific Session 4: Membrane lipids and signaling
Chairs: Claudia Stäubert / Georg Künze

• Presentation from selected abstracts
• Modulation of GPCR signaling by plasma lipids
  Alejandra Tomas Catala
• Membrane-Mediated Allosteric Action of Serotonin on a Noncognate G-Protein-Coupled Receptor
  Daniel Huster
  
• Challenges in identifying lipid GPCRs – Potential SPM receptors as an example
  Stefan Offermanns

2:30 - 4:00 PM AM | Plenary Session 2: New insights into pathogenesis of CVD
Chairs: Ulrich Laufs / Ioanna Gouni-Berthold

• Pathophysiology of triglyceride-rich lipoproteins
  Borge Nordestgaard
• Clonal Hematopoesis of Indeterminate Potential
  Peter Libby

Scientific Session 5: Sex-differences in cardio-metabolic disease
Chairs: Alexander Bartelt / Arnold von Eckardstein

• The effect of sex and gender on the biology of atheresclerosis
  Katariina Öörni
• Sex differences in the immune response in cardiovascular disease
  Sabine Steffens
• Data on high-risk subgroups from large clinical trials
  Johan Wouter Jukema

Scientific Session 6: Epigenetic aspects of cardiometabolic diseases
Chairs: Peter Kovacs / Maria Keller

• Leveraging omics to understand personalized responses to dietary interventions
  Iris Shai
• SWAT cells and the suppressed thermogenesis in human inguinal adipose tissue
  Camilla Scheele
• Hibernation as a Model for Adipose-Mediated Metabolic Regulation and Its Translational Potential
  Sören Nielsen
  

FRIDAY, DECEMBER 12, 2025

Scientific Session 7: Mechanisms of obesity: updates from the clinic
Chairs: Matthias Blüher / Kathrin Landgraf

• Presentation from selected abstracts
• Circadian disruption and inflammation in age-differential vulnerabilities to weight loss and cycling
  Assaf Rudich
• Adipose tissue mitochondria in obesity and weight loss – insights from twin cohorts and intervention studies
  Kirsi H Pietiläinen
• New insights into circadian and temperature control of lipid cycling in adipocytes
  Zach Gerhart-Hines

Scientific Session 8: Priming of cardiovascular disease early in life
Chairs: Ana Zenclussen / Sandra Blois

• Presentation from selected abstracts
• Maternal polycystic ovary syndrome and Offspring's Risk of Cardiovascular diseases
  Krisztina László
• Priming of offspring health by male-tract factors
  Rafaelle Teperino
• Placental hormones programme maternal hepatic metabolism across pregnancy with post-partum effects
  Jorge Lopez-Tello

Scientific Session 9: Insigths into new approaches to lipid lowering
Chairs: Uta Ceglarek / Ralph Burkhardt

• Presentation from selected abstracts
• New lipid drugs in clinical development
  Ulrich Laufs
  
• Challenges and opportunities in Lp(a) analysis
  Matthias Nauck
• Health economics of lipid lowering therapies
  Winfried März

Scientific Session 10: From big data to diagnostics in lipid disorders and related diseases
Chairs: Markus Scholz / Kristin Reiche

• Presentation from selected abstracts
• Using lipidomics to understand the role of membrane lipids in driving thrombosis in human disease
  Valerie O‘Donnell
• Multi-omics in acute and chronic coronary syndrome
  Leo Nicolai
• Single-cell analysis in diabetic kidneys
  Michael Sören Balzer

1:00 - 2:20 PM | Plenary Session 3: Thromboinflammatin in CVD
Chairs: Shrey Kohli / Leo Nicolai

• Thromboinflammation and protease activated receptors
  Wolfram Ruf
• Immunothrombosis in myocardial infarction
  Amin Polzin
• Crosstalk of Thromboinflammation in Cardiovascular and Infectious Diseases
  Thomas Renne

Scientific Session 11: Patient stratification
Chairs: Thomas Ebert / Rolf Wachter

• Polygenic risk scores
  Anne Tybjærg-Hansen
• Identification of two types of steatotic liver disease
  Stefano Romeo
• Different subtypes of statin-intolerance
  Paulina Stürzebecher